1964: The Year in Smoking—Race, Cigarettes, and Capitalism

Editor’s Note: Today’s post comes from contributing editor Sarah Brady Siff, a visiting assistant professor at the Moritz College of Law at The Ohio State University, in affiliation with the Drug Enforcement and Policy Center (DEPC). The superb historian of medicine Keith Wailoo has just written Pushing Cool: Big Tobacco, Racial Marketing, and the Untold Story of theContinue reading “1964: The Year in Smoking—Race, Cigarettes, and Capitalism”

Ergot and the First Roots of the FDA

Editor’s Note: Today’s post comes from Naomi Rendina. Rendina is a PhD candidate at Case Western Reserve University. She is expected to defend her dissertation, Pushing Too Hard: Pharmaceuticals and the Nature of Childbirth, in early March 2020. Here she explores the role a controversy of ergot played in creating the Food and Drug Administration (FDA),Continue reading “Ergot and the First Roots of the FDA”

Big Nicotine, Part II: Addiction and the “Cult of Pharmacology”

Last month, the U.S. Food and Drug Administration announced its intention to lower the nicotine content of cigarettes to, ideally, “minimally or nonaddictive” levels. Public health advocates celebrated the decision; on the other hand, Big Tobacco investors began dumping shares at the prospect of supplying an ever-more-elastic demand. Cigarette critics and capitalists alike belong toContinue reading “Big Nicotine, Part II: Addiction and the “Cult of Pharmacology””

%d bloggers like this: